Stock Analysis

Have Henry Schein Insiders Been Selling Stock?

NasdaqGS:HSIC
Source: Shutterstock

We'd be surprised if Henry Schein, Inc. (NASDAQ:HSIC) shareholders haven't noticed that the Chief Executive Officer of North America Distribution Group, Bradford Connett, recently sold US$478k worth of stock at US$74.28 per share. On the bright side, that sale was only 8.1% of their holding, so we doubt it's very meaningful, on its own.

Check out our latest analysis for Henry Schein

Henry Schein Insider Transactions Over The Last Year

In the last twelve months, the biggest single sale by an insider was when the Executive VP, Mark Mlotek, sold US$1.9m worth of shares at a price of US$76.68 per share. So we know that an insider sold shares at around the present share price of US$72.88. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).

Henry Schein insiders didn't buy any shares over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
NasdaqGS:HSIC Insider Trading Volume March 27th 2024

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

Does Henry Schein Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It's great to see that Henry Schein insiders own 1.4% of the company, worth about US$135m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

So What Do The Henry Schein Insider Transactions Indicate?

Insiders sold stock recently, but they haven't been buying. Looking to the last twelve months, our data doesn't show any insider buying. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Henry Schein. At Simply Wall St, we found 2 warning signs for Henry Schein that deserve your attention before buying any shares.

But note: Henry Schein may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Valuation is complex, but we're helping make it simple.

Find out whether Henry Schein is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:HSIC

Henry Schein

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide.

Undervalued with excellent balance sheet.